Work

Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analyses

Year: 2025
Type: article
Abstract: analyses highlights CC as a promising repurposed therapeutic candidate for NPC and supports further preclinical evaluation. See also the graphical abstract(Fig. 1).
Language: English
Open Access status: diamond
OpenAlex ID: W7124423944
FWCI: 0.485
Cites:
Cited by: 1
Related to: